DME: OIG HANGS UP ON DME TELEMARKETERS

Why This Topic Matters

The piece is relevant because it connects supplier marketing practices with federal fraud-and-abuse scrutiny, including potential False Claims Act exposure. It helps readers understand the compliance environment surrounding Medicare beneficiary contact and why telemarketing practices can trigger investigation.

Article Sections

1. Overview of the OIG Special Fraud Alert

   Introduces the OIG alert and the general concern about supplier marketing practices involving Medicare beneficiaries. Frames the compliance issue for durable medical equipment suppliers.

2. Telemarketing Ban and Exceptions

   Summarizes the general prohibition on unsolicited telephone sales contacts and notes that the alert discusses limited exceptions. The section centers on the broader policy context rather than operational details.

3. Enforcement and Compliance Risk

   Describes the enforcement posture discussed in the alert and the potential legal consequences for noncompliance. Emphasizes the article’s fraud-and-abuse and Medicare compliance focus.